[PL] Cyprus Economic Substance Requirements: What Your Company Genuinely Needs

[PL] Why Substance Matters

[PL] A Cyprus company is a Cyprus tax resident — and therefore subject to Cyprus tax law, including all its benefits — only if it is 'managed and controlled' from Cyprus. This is the foundational test under Article 2 of the Cyprus Income Tax Law.

[PL] Without genuine management and control from Cyprus, the company may be treated as a tax resident of another country (wherever the effective management actually takes place), potentially triggering: tax liability in that other country on all profits; denial of double tax treaty benefits between Cyprus and third countries; disqualification from IP Box, participation exemption, and other Cyprus-specific tax reliefs; and regulatory scrutiny under CFC (Controlled Foreign Company) rules in the shareholders' home country.

[PL] Beyond the tax question, inadequate substance has become a direct compliance risk. Cyprus regulators and banks conduct substance reviews, and enforcement actions have increased significantly since 2022.

[PL] What 'Management and Control' Actually Means

[PL] Management and control is determined by substance over form. A company is managed and controlled from the location where the real strategic decisions are made — not necessarily where the company is registered or where its paperwork says it operates.

[PL] The Cyprus Tax Department, following OECD guidelines, assesses management and control based on the following factors.

[PL] Core Income-Generating Activities (CIGAs)

[PL] For companies benefiting from specific regimes — notably the IP Box — the OECD modified nexus approach and Cyprus's implementation require that the Core Income-Generating Activities (CIGAs) are performed in Cyprus. CIGAs are the substantive activities that justify the income: for an IP holding company, this means actual R&D, development, and enhancement activities performed by qualified personnel in Cyprus, not just ownership of IP.

[PL] A Cyprus company that owns intellectual property but performs no actual R&D in Cyprus and employs no qualified tech staff locally will have a nexus fraction close to zero — eliminating the IP Box benefit in practice, regardless of the legal structure.

minimum Substance Checklist

• [PL] At least one Cyprus-resident director on the board who actively participates in board decisions
• [PL] Board meetings held in Cyprus at least quarterly (or more frequently for active companies); agendas and minutes maintained
• [PL] A genuine physical office address in Cyprus (not just a registered address) — coworking space acceptable for smaller companies at an early stage but should match business scale
• [PL] All strategic decisions (major contracts, banking arrangements, corporate structure changes) made at Cyprus board level
• [PL] Company bank account(s) held at a Cyprus bank or EU-regulated bank, operated from Cyprus
• [PL] Accounting records maintained in Cyprus; bookkeeping performed by Cyprus-based accountants
• [PL] Annual statutory audit conducted by ICPAC-licensed auditors
• [PL] UBO Register up to date and annual confirmation filed
• [PL] All director and secretary changes notified to the Registrar within 14 days

[PL] What Happens Without Adequate Substance

[PL] The consequences of inadequate substance have escalated significantly.

[PL] From a tax perspective: the company may be treated as a tax resident of another jurisdiction (where effective management is actually located), triggering full tax exposure in that jurisdiction; double tax treaty benefits may be denied under the anti-abuse provisions (Principal Purpose Test) of the OECD Multilateral Instrument; and specific regime benefits (IP Box, participation exemption) may be disallowed.

[PL] From a regulatory and banking perspective: Cyprus banks have substantially increased substance due diligence since 2021; accounts are refused or closed where substance is assessed as inadequate; the Cyprus AML framework imposes significant penalties on obliged entities (banks, accountants, lawyers) that maintain relationships with shell structures.

[PL] From an enforcement perspective: in 2024, Cyprus authorities conducted 150+ penalty actions against superficial substance arrangements, with total penalties exceeding €1.2 million. The AML law was amended in 2024 to increase maximum penalties from €100,000 to €350,000 for serious substance breaches.

[PL] Building Genuine Substance: Practical Steps

1. [PL] Appoint at least one genuinely active Cyprus-resident director — not a passive nominee, but someone who attends board meetings, understands the business, and makes real decisions
2. [PL] Hold board meetings physically in Cyprus at least quarterly — use real agendas, make real decisions, keep signed minutes with sufficient detail to demonstrate genuine deliberation
3. [PL] Maintain a genuine office — at minimum a dedicated desk in a reputable business centre or co-working space; for active operations, a serviced or own office is expected
4. [PL] Hire qualified Cyprus-based staff if the business scale warrants it — for IP companies, qualified R&D staff; for trading companies, operational staff
5. [PL] Ensure all major contracts, banking decisions, and strategic choices are approved at Cyprus board level with documented resolutions
6. [PL] Use Cyprus banks (Bank of Cyprus, Hellenic Bank, RCB) or EU-regulated banks with Cyprus operations — operate accounts from Cyprus
7. [PL] Engage ICPAC-licensed accountants for all accounting, audit, and tax compliance
8. [PL] Document everything — a well-maintained corporate governance file is the single most important defence in a substance challenge